BRIEF-Biogen says Tecfidera data confirm strong, sustained efficacy in newly diagnosed MS

* Tecfidera data confirm strong and sustained efficacy in newly diagnosed ms patients and real-world effectiveness Source text for Eikon: Further company coverage: (Bengaluru Newsroom +1-646-223-8780)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.